Table 1:

Baseline characteristics of patients admitted to intensive care unit (ICU), by frailty status

CharacteristicGroup; no. (%)of patients*p value
Frail
n = 138
Not frail
n = 283
Age, yr, mean ± SD69 ± 1066 ± 100.007
Sex, female66 (47.8)97 (34.3)0.007
Race, white114 (82.6)240 (84.8)0.6
Marital status
 Married or common law87 (63.0)189 (66.8)0.45
 Never married4 (2.9)23 (8.1)0.03
 Widowed25 (18.1)28 (9.9)0.02
Less than high school education39 (28.3)54 (19.1)0.03
Residence< 0.001
 Living at home independently58 (42.0)244 (86.2)
 Living at home with help64 (46.4)35 (12.4)
 Other9 (6.5)3 (1.2)
Able to perform activity independently§
 Taking a bath79 (57.2)274 (96.8)< 0.001
 Walking77 (55.8)259 (91.5)< 0.001
 Taking medications90 (65.2)270 (95.4)< 0.001
 Managing own “nances102 (73.9)273 (96.5)< 0.001
Elixhauser comorbidity score, mean ± SD10 ± 97 ± 7< 0.001
No. of prescription medications, mean ± SD8.9 ± 55.5 ± 4< 0.001
Prior hospital admission77 (55.8)99 (35.0)< 0.001
Prior ICU admission37 (26.8)63 (22.3)0.3
Source of transfer to ICU0.5
 Ward72 (52.2)167 (59.0)
 Emergency department40 (29.0)72 (25.4)
 Another hospital24 (17.4)39 (13.8)
 Other2 (1.4)5 (1.8)
Postoperative ICU admission**34 (24.6)108 (38.2)0.006
Cardiac arrest††10 (7.2)21 (7.4)0.9
Rapid response team††36 (26.1)74 (26.1)0.9
APACHE II score,†† mean ± SD21 ± 719 ± 7< 0.001
SOFA score,†† mean ± SD8 ± 47 ± 40.1
Limitation of medical therapy‡‡47 (34.1)34 (12.0)< 0.001
  • Note: APACHE = Acute Physiology and Chronic Health Evaluation, CSHA = Canadian Study of Health and Ageing, SD = standard deviation, SOFA = Sequential Organ Failure Assessment.

  • * Unless stated otherwise.

  • t test for comparisons of continuous data and χ2 test for comparisons of categorical data.

  • Continuing care facility, subacute care facility or other.

  • § Score of 0 on the CSHA Function Scale.

  • In the year before enrolment.

  • ** Surgery within 48 hours before ICU admission.

  • †† At time of ICU admission.

  • ‡‡ Limitation in the provision of ICU-specific life-sustaining therapy (e.g., cardiopulmonary resuscitation, advanced cardiac life support, mechanical ventilation, use of vasoactives, renal replacement therapy) documented in the medical record.